Osteoarthritis year in review 2026: Imaging.
Authors
Affiliations (4)
Affiliations (4)
- The Jikei University School of Medicine, Tokyo, JAPAN. Electronic address: [email protected].
- MASSACHUSETTS GENERAL HOSPITAL.
- Universitatsklinikum Erlangen.
- Boston University Chobanian & Avedisian School of Medicine.
Abstract
To narratively review the literature on osteoarthritis (OA) imaging published between March 2025 and March 2026 and to identify current trends and emerging directions in imaging-based OA research. PubMed was searched for original English-language human in vivo studies published during the period. Trends by imaging modality and target-joint distributions were analyzed. For narrative synthesis, studies were selected subjectively by consensus among the authors based on methodological novelty, clinical or trial relevance, contribution to understanding OA pathophysiology or progression, and potential future impact. Of 1,910 publications identified, 1,035 specified a target joint. Approximately 70% investigated the knee, followed by the hip. Radiography and ultrasound yielded the most records, encompassing heterogeneous applications such as trial eligibility and image-guided procedures. Although publication counts for these modalities have gradually declined in recent years, those for MRI have remained stable. Semiquantitative MRI analysis linked worsening bone marrow lesions and Hoffa-synovitis to greater cartilage loss, and suggested differing associations between injection type and subsequent structural progression. Quantitative MRI studies linked cartilage T2 to BMI in a population-based cohort, while muscle radiomics predicted incident knee OA. Among emerging technique, magnetic resonance fingerprinting (MRF) provided rapid cartilage T2 mapping, and [18F]NaF PET-MRI linked increased metabolic activity at enthesis to worse knee-related outcomes. For clinical-trial eligibility, MRI detected exclusionary abnormalities in 10% of otherwise DMOAD-eligible knees. AI-related publications gradually increased, with applications including prediction of future total knee replacement (TKR) and automated tissue segmentation. Studies highlight the use of imaging for longitudinal assessment of structural progression, clinical-trial eligibility, and quantitative tissue characterization. MRI remains central to understanding disease mechanisms and progression, while emerging techniques such as MRF and [18F]NaF PET-MRI broaden quantitative and metabolic assessment. AI may support prediction of future TKR and automated cartilage morphometry.